BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 30214063)

  • 41. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia.
    Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; Löwenberg B; Delwel R
    Exp Hematol; 2003 Nov; 31(11):1066-72. PubMed ID: 14585371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells.
    Rommer A; Steinmetz B; Herbst F; Hackl H; Heffeter P; Heilos D; Filipits M; Steinleitner K; Hemmati S; Herbacek I; Schwarzinger I; Hartl K; Rondou P; Glimm H; Karakaya K; Krämer A; Berger W; Wieser R
    PLoS One; 2013; 8(2):e56308. PubMed ID: 23457546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of gene silencing pyrrole-imidazole polyamide targeting the TGF-beta1 promoter for treatment of progressive renal diseases.
    Matsuda H; Fukuda N; Ueno T; Tahira Y; Ayame H; Zhang W; Bando T; Sugiyama H; Saito S; Matsumoto K; Mugishima H; Serie K
    J Am Soc Nephrol; 2006 Feb; 17(2):422-32. PubMed ID: 16371433
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preclinical Study of DNA-Recognized Peptide Compound Pyrrole-Imidazole Polyamide Targeting Human TGF-β1 Promoter for Progressive Renal Diseases in the Common Marmoset.
    Otsuki M; Fukuda N; Inoue T; Mineshige T; Otsuki T; Horikoshi S; Endo M; Abe M
    Molecules; 2019 Sep; 24(17):. PubMed ID: 31480595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RUNX1-EVI1 induces dysplastic hematopoiesis and acute leukemia of the megakaryocytic lineage in mice.
    Nakamura Y; Ichikawa M; Oda H; Yamazaki I; Sasaki K; Mitani K
    Leuk Res; 2018 Nov; 74():14-20. PubMed ID: 30278283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
    Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
    Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
    Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia.
    Jin W; Wu K; Li YZ; Yang WT; Zou B; Zhang F; Zhang J; Wang KK
    Oncogene; 2013 Apr; 32(15):1978-87. PubMed ID: 22641217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Pyrrole-Imidazole Polyamides Targeting Human TGF-β1 on the Malignant Phenotypes of Liver Cancer Cells.
    Takagi K; Midorikawa Y; Takayama T; Abe H; Fujiwara K; Soma M; Nagase H; Miki T; Fukuda N
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32585841
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
    Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
    Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.
    Liu J; Lu W; Liu S; Wang Y; Li S; Xu Y; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
    Leuk Res; 2018 May; 68():15-21. PubMed ID: 29518627
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of a novel gene silencer pyrrole-imidazole polyamide targeting human connective tissue growth factor.
    Wan JX; Fukuda N; Ueno T; Watanabe T; Matsuda H; Saito K; Nagase H; Matsumoto Y; Matsumoto K
    Biol Pharm Bull; 2011; 34(10):1572-7. PubMed ID: 21963497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis.
    Yamaoka A; Suzuki M; Katayama S; Orihara D; Engel JD; Yamamoto M
    Blood Adv; 2020 Apr; 4(8):1722-1736. PubMed ID: 32330245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pyrrole-imidazole polyamide-mediated silencing of KCNQ1OT1 expression induces cell death in Wilms' tumor cells.
    Yoshizawa S; Fujiwara K; Sugito K; Uekusa S; Kawashima H; Hoshi R; Watanabe Y; Hirano T; Furuya T; Masuko T; Ueno T; Fukuda N; Soma M; Ozaki T; Koshinaga T; Nagase H
    Int J Oncol; 2015 Jul; 47(1):115-21. PubMed ID: 25998555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-133 regulates Evi1 expression in AML cells as a potential therapeutic target.
    Yamamoto H; Lu J; Oba S; Kawamata T; Yoshimi A; Kurosaki N; Yokoyama K; Matsushita H; Kurokawa M; Tojo A; Ando K; Morishita K; Katagiri K; Kotani A
    Sci Rep; 2016 Jan; 6():19204. PubMed ID: 26754824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The adverse impact of ecotropic viral integration site-1 (EVI1) overexpression on the prognosis of acute myeloid leukemia with KMT2A gene rearrangement in different risk stratification subtypes.
    Liu XX; Pan XA; Gao MG; Kong J; Jiang H; Chang YJ; Zhang XH; Wang Y; Liu KY; Chen Z; Zhao XS; Huang XJ
    Int J Lab Hematol; 2023 Apr; 45(2):195-203. PubMed ID: 36358022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription.
    Maicas M; Vázquez I; Vicente C; García-Sánchez MA; Marcotegui N; Urquiza L; Calasanz MJ; Odero MD
    Oncogene; 2013 Apr; 32(16):2069-78. PubMed ID: 22689058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
    Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
    J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. GPR56 contributes to the development of acute myeloid leukemia in mice.
    Daria D; Kirsten N; Muranyi A; Mulaw M; Ihme S; Kechter A; Hollnagel M; Bullinger L; Döhner K; Döhner H; Feuring-Buske M; Buske C
    Leukemia; 2016 Aug; 30(8):1734-41. PubMed ID: 27063597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia.
    Su G; Lian X; Tan D; Tao H; Liu H; Chen S; Yin H; Wu D; Yin B
    Leuk Lymphoma; 2015 Feb; 56(2):472-9. PubMed ID: 24828867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.